157 related articles for article (PubMed ID: 14620923)
1. Candesartan reduces oxidative stress and inflammation in patients with essential hypertension.
Dohi Y; Ohashi M; Sugiyama M; Takase H; Sato K; Ueda R
Hypertens Res; 2003 Sep; 26(9):691-7. PubMed ID: 14620923
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy.
Ogawa S; Mori T; Nako K; Kato T; Takeuchi K; Ito S
Hypertension; 2006 Apr; 47(4):699-705. PubMed ID: 16505207
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients.
Koh KK; Ahn JY; Han SH; Kim DS; Jin DK; Kim HS; Shin MS; Ahn TH; Choi IS; Shin EK
J Am Coll Cardiol; 2003 Sep; 42(5):905-10. PubMed ID: 12957441
[TBL] [Abstract][Full Text] [Related]
4. Candesartan decreases carotid intima-media thickness by enhancing nitric oxide and decreasing oxidative stress in patients with hypertension.
Ono H; Minatoguchi S; Watanabe K; Yamada Y; Mizukusa T; Kawasaki H; Takahashi H; Uno T; Tsukamoto T; Hiei K; Fujiwara H
Hypertens Res; 2008 Feb; 31(2):271-9. PubMed ID: 18360047
[TBL] [Abstract][Full Text] [Related]
5. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K
Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747
[TBL] [Abstract][Full Text] [Related]
6. Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure.
Sakamoto M; Suzuki H; Hayashi T; Iuchi H; Isaka T; Sakamoto N; Kayama Y; Tojo K; Yoshimura M; Utsunomiya K
Cardiovasc Diabetol; 2012 Oct; 11():118. PubMed ID: 23034088
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of combined therapy with lacidipine and candesartan in obese hypertensive patients.
Ashcheulova T; Gerasimchuk N; Kovalyova O; Honchar O
Rom J Intern Med; 2018 Dec; 56(4):257-264. PubMed ID: 30521476
[TBL] [Abstract][Full Text] [Related]
8. Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients.
Koh KK; Quon MJ; Han SH; Chung WJ; Ahn JY; Kim JA; Lee Y; Shin EK
Diabetes Care; 2006 Feb; 29(2):195-201. PubMed ID: 16443859
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of candesartan cilexetil (the new angiotensin II antagonist) on systemic and renal haemodynamics in hypertensive patients.
Fridman K; Andersson OK; Wysocki M; Friberg P; Sunzel M
Eur J Clin Pharmacol; 1998 Sep; 54(7):497-501. PubMed ID: 9832289
[TBL] [Abstract][Full Text] [Related]
10. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
London G; Schmieder R; Calvo C; Asmar R
Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory and metabolic effects of candesartan in hypertensive patients.
Koh KK; Quon MJ; Han SH; Chung WJ; Lee Y; Shin EK
Int J Cardiol; 2006 Mar; 108(1):96-100. PubMed ID: 16246439
[TBL] [Abstract][Full Text] [Related]
12. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
[TBL] [Abstract][Full Text] [Related]
13. [Effect of angiotensin II type 1 receptor antagonist on oxidative stress markers in type 2 diabetic patients with hypertension].
Sato N; Kase H; Kato T; Kasai K
Nihon Rinsho; 2003 Jul; 61(7):1245-9. PubMed ID: 12877092
[TBL] [Abstract][Full Text] [Related]
14. Candesartan effect on inflammation in hypertension.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Hypertens Res; 2010 Mar; 33(3):209-13. PubMed ID: 20075928
[TBL] [Abstract][Full Text] [Related]
15. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
[TBL] [Abstract][Full Text] [Related]
16. The effect of candesartan on pentraxin-3 plasma levels as marker of endothelial dysfunction in patients with essential arterial hypertension.
Buda V; Andor M; Cristescu C; Voicu M; Cochera F; Tuduce P; Petrescu L; Tomescu MC
Ir J Med Sci; 2017 Aug; 186(3):621-629. PubMed ID: 28220370
[TBL] [Abstract][Full Text] [Related]
17. Effects of combined candesartan and ACE inhibitors on BNP, markers of inflammation and oxidative stress, and glucose regulation in patients with symptomatic heart failure.
White M; Lepage S; Lavoie J; De Denus S; Leblanc MH; Gossard D; Whittom L; Racine N; Ducharme A; Dabouz F; Rouleau JL; Touyz R
J Card Fail; 2007 Mar; 13(2):86-94. PubMed ID: 17395047
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of treating prehypertension with an angiotensin-receptor blocker.
Julius S; Nesbitt SD; Egan BM; Weber MA; Michelson EL; Kaciroti N; Black HR; Grimm RH; Messerli FH; Oparil S; Schork MA;
N Engl J Med; 2006 Apr; 354(16):1685-97. PubMed ID: 16537662
[TBL] [Abstract][Full Text] [Related]
19. Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
Galle J; Schwedhelm E; Pinnetti S; Böger RH; Wanner C;
Nephrol Dial Transplant; 2008 Oct; 23(10):3174-83. PubMed ID: 18450829
[TBL] [Abstract][Full Text] [Related]
20. A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension.
Lee JH; Yang DH; Hwang JY; Hur SH; Cha TJ; Kim KS; Kim MH; Chun KJ; Cha GS; Hong GR; Lee SG; Kim DS; Kim DI; Chae SC
Clin Ther; 2016 Jun; 38(6):1485-1497. PubMed ID: 27161546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
